Back to jobs

Director, Regional Marketing & Customer Engagement

Boston, San Diego, Remote

Are you ready to join a team committed to making a meaningful impact on cancer treatment through the discovery and development of precision medicines? At Kura Oncology, you have an opportunity to be a part of something bigger, with a lasting impact that you can be proud of.

At Kura Oncology, we are working to change the paradigm and improve the science of cancer treatment. As an organization, we strive to cultivate a diverse and talented professional culture driven to develop precision medicine therapeutics.

As we continue to build a leading biotech organization with a strong culture, a patient-focused mindset and a team focused on relentless execution, we are looking for innovative, passionate professionals to join us and make our vision a reality.

To succeed at Kura, you will need to have a demonstrated ability for excellence in drug discovery and development and a roll-up your sleeves attitude. The ideal candidate will possess a values-driven work style where integrity and grit drive all behaviors, decisions, and actions.

Director of Regional Marketing & Key Customer Engagements

We are seeking a Director of Regional Marketing & Key Customer Engagements who will shape the strategy, planning, and execution for the Associate Directors of Regional Marketing, while also acting as a Regional Marketing Lead for a given Region. This role involves overseeing the strategic engagement with Hematologist-Oncologist Thought Leaders at both National and Regional levels. The Director of Regional Marketing & Key Customer Engagements will provide leadership of the development, planning and execution of Thought Leader engagement strategy, plans and execution, ensuring alignment with the organization’s corporate strategy, brand positioning, and lifecycle management to ensure brand success and optimization ongoing.

Essential Job Functions

  • Lead and manage a team of Regional Marketing Leaders, defining roles and responsibilities, and executing a hiring plan to optimize team structure.
  • Act as a Regional Marketing Lead, driving regional marketing strategies and initiatives to support delivery and optimization of brand positioning, brand strategy and life-cycle planning.
  • Collaborate closely with internal stakeholders across commercial functions to identify areas for Thought Leader insights, and to align strategies and execute tactics effectively.
  • Partner with field medical leadership to ensure a coordinated, compliant approach in the external engagement with National and Regional Thought Leaders
  • Develop and execute the National and Regional Thought Leader strategy, translating it into commercial insights, messaging and contributing to broader communication strategies and plans.
  • Build and maintain relationships with Hematology-Oncology Thought Leaders to ensure effective collaboration and support for investigational therapies and future anticipated FDA-approved treatments.
  • Plan and oversee Thought Leader engagements at various conferences, events, and meetings, ensuring compliance with regulatory and legal standards.
  • Collaborate regularly with cross-functional brand team to provide strategic input on insights to inform strategy, planning, messaging, tactics, and program development.
  • Identify and prioritize investment opportunities for strategic programs that support business goals.
  • Foster an environment that prioritizes positive patient, caregiver, and healthcare provider experiences.
  • Adapt strategies as needed to support pre-launch preparations and post-launch pull-through, navigating a dynamic market.
  • Collaborate cross-functionally to execute business plans and contribute to the Customer Engagement team's objectives.
  • Manage CRM to maintain accurate account and contact details.
  • Collaborate with Marketing Operations lead to build a speaker bureau, train speakers and support speaker program management and monitoring.
  • Responsible for annual planning and management oversite of the functional budgets and return on investments.
  • Partner with Analytics and Insights to better understand regional treatment pattern variations to inform peer to peer and insight program placement
  • Ensure all activities and practices adhere to regulatory and legal compliance standards.

JOB SPECIFICATIONS:

  • BA/BS or healthcare equivalent degree required, and advanced degree (ex. MBA, PhD) preferred.
  • Minimum 8+ years of previous pharmaceutical, biotech, and/or medical experience in Hematology/Oncology with a strong knowledge of the pharmaceutical marketplace and deep understanding of industry and broader trends within the healthcare landscape.
  • Minimum of 3+ years combined experience in Key Customer Engagement and/or Regional Marketing in Hematology/Oncology required.
  • Proven ability to access and influence C/D-Suite level stakeholders.
  • Demonstrated strong strategic vision, leadership, and management skills.
  • Demonstrate strong interpersonal, verbal and written communication skills.
  • Ability to form strong, constructive internal and external professional relationships.
  • Successful new product and indication expansion launches in Hematology, Oncology and other rare diseases required.
  • Prior pharma/biotech start-up experience preferred.
  • Technologically savvy and committed to leveraging data and advanced analytics daily to drive business results.
  • Ability to travel on a frequent overnight basis, with occasional weekend travel to medical congresses, depending on business needs.

The base range for a Director is $211,000 - $255,000 per year. Individual pay may vary based on additional factors, including, and without limitation, job-related skills, experience, work location, and relevant education or training. Kura's compensation package also includes generous benefits, equity, and participation in an annual target bonus.

Kura’s Values that are used for candidate selection and performance assessments:

  • We work as one for patients
  • We are goal-focused and deliver with excellence
  • We are science-driven courageous innovators
  • We strive to bring out the best in each other and ourselves

The Kura Package

  • Career advancement/ development opportunities
  • Competitive comp package
  • Bonus
  • 401K + Employer contributions
  • Generous stock options
  • ESPP Plan
  • 20 days of PTO to start
  • 18 Holidays  (Including Summer & Winter Break)
  • Generous Benefits Package with a variety of plans available with a substantial employer match
  • Paid Paternity/Maternity Leave
  • In-Office Catered lunches
  • Home Office Setup
  • Lifestyle Spending Stipend
  • Commuter Stipend (Boston Office)
  • Regular employee social activities, including happy hours, monthly birthday celebrations, Kura Koffee Talks, and much more!

Kura Oncology is a clinical-stage biopharmaceutical company discovering and developing personalized therapeutics for the treatment of blood cancers and solid tumors. The company’s diverse pipeline consists of small molecules that target cancer signaling pathways where there is a strong scientific and clinical rationale to improve outcomes by identifying those patients most likely to benefit from treatment. Kura Oncology’s approach to drug development is focused on rapidly translating novel science into life-saving medicines. Our goal is to help patients with cancer lead better, longer lives. Kura Oncology has offices in San Diego, California, and Boston, Massachusetts.

Kura’s pipeline consists of three investigational drug candidates: ziftomenib, tipifarnib and KO-2806. Ziftomenib, a once-daily, oral drug candidate targeting the menin-KMT2A protein-protein interaction, has received Breakthrough Therapy Designation for the treatment of R/R NPM1-mutant acute myeloid leukemia (AML). Kura has completed enrollment in a Phase 2 registration-directed trial of ziftomenib in R/R NPM1-mutant AML (KOMET-001). The Company is also conducting a series of clinical trials to evaluate ziftomenib in combination with current standards of care in newly diagnosed and R/R NPM1-mutant and KMT2A-rearranged AML. Tipifarnib, a potent and selective farnesyl transferase inhibitor (FTI), is currently in a Phase 1/2 trial in combination with alpelisib for patients with PIK3CA-dependent head and neck squamous cell carcinoma (KURRENT-HN). Kura is also evaluating KO-2806, a next-generation FTI, in a Phase 1 dose-escalation trial as a monotherapy and in combination with targeted therapies (FIT-001). For additional information, please visit Kura’s website at www.kuraoncology.com and follow us on X and LinkedIn.

Kura Oncology is committed to creating a diverse environment and is proud to be an equal opportunity employer. All qualified applicants will receive consideration for employment without regard to race, color, religion, gender, gender identity or expression, sexual orientation, national origin, genetics, disability, age, or veteran status. 

Apply for this job

*

indicates a required field

Resume/CV*
,,Google Drive,or

Accepted file types: pdf, doc, docx, txt, rtf

Cover Letter
,,Google Drive,or

Accepted file types: pdf, doc, docx, txt, rtf

Select...
Select...
Select...
Select...

Education

Select...
Select...
Select...
Select...
Select...

Voluntary Self-Identification

For government reporting purposes, we ask candidates to respond to the below self-identification survey. Completion of the form is entirely voluntary. Whatever your decision, it will not be considered in the hiring process or thereafter. Any information that you do provide will be recorded and maintained in a confidential file.

As set forth in Kura Oncology’s Equal Employment Opportunity policy, we do not discriminate on the basis of any protected group status under any applicable law.

Select...
Select...
Race & Ethnicity Definitions

If you believe you belong to any of the categories of protected veterans listed below, please indicate by making the appropriate selection. As a government contractor subject to the Vietnam Era Veterans Readjustment Assistance Act (VEVRAA), we request this information in order to measure the effectiveness of the outreach and positive recruitment efforts we undertake pursuant to VEVRAA. Classification of protected categories is as follows:

A "disabled veteran" is one of the following: a veteran of the U.S. military, ground, naval or air service who is entitled to compensation (or who but for the receipt of military retired pay would be entitled to compensation) under laws administered by the Secretary of Veterans Affairs; or a person who was discharged or released from active duty because of a service-connected disability.

A "recently separated veteran" means any veteran during the three-year period beginning on the date of such veteran's discharge or release from active duty in the U.S. military, ground, naval, or air service.

An "active duty wartime or campaign badge veteran" means a veteran who served on active duty in the U.S. military, ground, naval or air service during a war, or in a campaign or expedition for which a campaign badge has been authorized under the laws administered by the Department of Defense.

An "Armed forces service medal veteran" means a veteran who, while serving on active duty in the U.S. military, ground, naval or air service, participated in a United States military operation for which an Armed Forces service medal was awarded pursuant to Executive Order 12985.

Select...

Voluntary Self-Identification of Disability

Form CC-305
Page 1 of 1
OMB Control Number 1250-0005
Expires 04/30/2026

Why are you being asked to complete this form?

We are a federal contractor or subcontractor. The law requires us to provide equal employment opportunity to qualified people with disabilities. We have a goal of having at least 7% of our workers as people with disabilities. The law says we must measure our progress towards this goal. To do this, we must ask applicants and employees if they have a disability or have ever had one. People can become disabled, so we need to ask this question at least every five years.

Completing this form is voluntary, and we hope that you will choose to do so. Your answer is confidential. No one who makes hiring decisions will see it. Your decision to complete the form and your answer will not harm you in any way. If you want to learn more about the law or this form, visit the U.S. Department of Labor’s Office of Federal Contract Compliance Programs (OFCCP) website at www.dol.gov/ofccp.

How do you know if you have a disability?

A disability is a condition that substantially limits one or more of your “major life activities.” If you have or have ever had such a condition, you are a person with a disability. Disabilities include, but are not limited to:

  • Alcohol or other substance use disorder (not currently using drugs illegally)
  • Autoimmune disorder, for example, lupus, fibromyalgia, rheumatoid arthritis, HIV/AIDS
  • Blind or low vision
  • Cancer (past or present)
  • Cardiovascular or heart disease
  • Celiac disease
  • Cerebral palsy
  • Deaf or serious difficulty hearing
  • Diabetes
  • Disfigurement, for example, disfigurement caused by burns, wounds, accidents, or congenital disorders
  • Epilepsy or other seizure disorder
  • Gastrointestinal disorders, for example, Crohn's Disease, irritable bowel syndrome
  • Intellectual or developmental disability
  • Mental health conditions, for example, depression, bipolar disorder, anxiety disorder, schizophrenia, PTSD
  • Missing limbs or partially missing limbs
  • Mobility impairment, benefiting from the use of a wheelchair, scooter, walker, leg brace(s) and/or other supports
  • Nervous system condition, for example, migraine headaches, Parkinson’s disease, multiple sclerosis (MS)
  • Neurodivergence, for example, attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder, dyslexia, dyspraxia, other learning disabilities
  • Partial or complete paralysis (any cause)
  • Pulmonary or respiratory conditions, for example, tuberculosis, asthma, emphysema
  • Short stature (dwarfism)
  • Traumatic brain injury
Select...

PUBLIC BURDEN STATEMENT: According to the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless such collection displays a valid OMB control number. This survey should take about 5 minutes to complete.